Through the normalization of gambling and increased access to a wide variety of gambling opportunities, as well as the stigma associated problem gambling, it is important to bring attention to gambling disorder, to educate the people of Maine about this public health issue and to find solutions to barriers we are currently facing in the prevention, intervention, treatment and recovery of problem gambling. This conference will feature expert speakers to lead conversations on trends in Maine and beyond, integrating problem gambling as a co-occurring disorder, recognizing the danger of suicide in problem gamblers and providing interventions and resources for safety, and guiding us to find solutions and ways to bring stakeholders to the table.
Early bird fee of $35.00 if paid before 5/29/2020.
Recovery
The words we choose have an impact. How we talk about drug use and people who use drugs is informed by our preconceived notions and internalized biases. When we use words like “clean,” we necessarily imply that the opposite is “dirty.” Opioid Use Disorder continues to be a highly stigmatized medical condition, despite many advancements in our understanding of the neurobiological, social, and environmental determinants that impact individual health. People with an Opioid Use Disorder continue to report high rates of discrimination from medical providers, service denials from government entities, and continued unfair targeting by law enforcement. The ramifications of stigma in care environments are far reaching and further compound the opioid crisis. During this workshop, participants will explore personal biases related to opioid use and examine the way that these biases present in language. We will consider the effects that stigmatizing speech and actions have on people who use drugs, and we will discuss how to create an affirming environment that will enhance care for people who use drugs. Registration fee includes a continental breakfast and lunch.
Individuals living with serious mental health conditions die on average 25 years earlier than the general population, most often from tobacco related cancer, heart disease, and lung disease.
If you work in the behavioral health field, you know that tobacco can be a difficult issue to address. Your clients – people with mental health diagnoses – are more likely to use tobacco, to smoke more and to have a harder time quitting than those without such a diagnosis. However, these individuals want to quit and CAN quit. But they may need some extra support.
Join other behavioral health professionals and MaineHealth Center for Tobacco Independence Training and Education staff for a half-day training to learn more about confronting tobacco use in individuals with behavioral health conditions.
2019 Clinical Opioid Update: Learning Objectives:
- Review latest research relating to opioid + pain prescribing practices
- Constantly consider harm reduction
- Discuss opioid use disorder and treatments
2019 Legal Opioid Update: Learning Objectives:
- Review impact of Chapter 488 in Maine
- Discuss opioid laws, rules and initiatives of the new administration
- Study Chapter 21 requirements & logical implementation
- Investigate methods to further transform local and regional prescribing
Co-Prescribing Benzodiazepines and Opioids: The Black Box of Increased Overdose Risk: Learning Objectives:
- Review the trends in benzodiazepine prescribing
- Evaluate risks of co-prescribing benzodiazepines and opioids
- Consider taper plans
- Recall importance of risk reduction
Registration is Free – Advanced Registration is required. Light snacks will be provided.
2019 Clinical Opioid Update: Learning Objectives:
- Review latest research relating to opioid + pain prescribing practices
- Constantly consider harm reduction
- Discuss opioid use disorder and treatments
2019 Legal Opioid Update: Learning Objectives:
- Review impact of Chapter 488 in Maine
- Discuss opioid laws, rules and initiatives of the new administration
- Study Chapter 21 requirements & logical implementation
- Investigate methods to further transform local and regional prescribing
Co-Prescribing Benzodiazepines and Opioids: The Black Box of Increased Overdose Risk: Learning Objectives:
- Review the trends in benzodiazepine prescribing
- Evaluate risks of co-prescribing benzodiazepines and opioids
- Consider taper plans
- Recall importance of risk reduction
Registration is Free – Advanced Registration is required. Light snacks will be provided.
2019 Clinical Opioid Update: Learning Objectives:
- Review latest research relating to opioid + pain prescribing practices
- Constantly consider harm reduction
- Discuss opioid use disorder and treatments
2019 Legal Opioid Update: Learning Objectives:
- Review impact of Chapter 488 in Maine
- Discuss opioid laws, rules and initiatives of the new administration
- Study Chapter 21 requirements & logical implementation
- Investigate methods to further transform local and regional prescribing
Co-Prescribing Benzodiazepines and Opioids: The Black Box of Increased Overdose Risk: Learning Objectives:
- Review the trends in benzodiazepine prescribing
- Evaluate risks of co-prescribing benzodiazepines and opioids
- Consider taper plans
- Recall importance of risk reduction
Registration is Free – Advanced Registration is required. Light snacks will be provided.
The words we choose have an impact. How we talk about drug use and people who use drugs is informed by our preconceived notions and internalized biases. When we use words like “clean,” we necessarily imply that the opposite is “dirty.” Opioid Use Disorder continues to be a highly stigmatized medical condition, despite many advancements in our understanding of the neurobiological, social, and environmental determinants that impact individual health. People with an Opioid Use Disorder continue to report high rates of discrimination from medical providers, service denials from government entities, and continued unfair targeting by law enforcement. The ramifications of stigma in care environments are far reaching and further compound the opioid crisis. During this workshop, participants will explore personal biases related to opioid use and examine the way that these biases present in language. We will consider the effects that stigmatizing speech and actions have on people who use drugs, and we will discuss how to create an affirming environment that will enhance care for people who use drugs.
Registration fee includes a continental breakfast and lunch.